Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Autoimmune (type 1) diabetes

Lindbladh, Ida ; Svärd, Agnes Andersson LU orcid and Lernmark, Åke LU orcid (2019) p.769-787
Abstract

Autoimmune (type 1) diabetes mellitus is a chronic disease without a cure. It affects primarily young people but may be diagnosed at any age. Strong genetic susceptibility characterizes the most common form of autoimmune diabetes in children younger than 18 years of age. Autoimmune diabetes is generally assumed to be hereditary, although the majority of patients do not have a family history of autoimmune diabetes. The etiology is not fully understood. However, the genetic susceptibility is strongly associated with genetic factors within the human leukocyte antigen (HLA) complex on chromosome 6. The role of HLA is associated with the development of islet autoimmunity, a stage marked by the appearance of autoantibodies against islet... (More)

Autoimmune (type 1) diabetes mellitus is a chronic disease without a cure. It affects primarily young people but may be diagnosed at any age. Strong genetic susceptibility characterizes the most common form of autoimmune diabetes in children younger than 18 years of age. Autoimmune diabetes is generally assumed to be hereditary, although the majority of patients do not have a family history of autoimmune diabetes. The etiology is not fully understood. However, the genetic susceptibility is strongly associated with genetic factors within the human leukocyte antigen (HLA) complex on chromosome 6. The role of HLA is associated with the development of islet autoimmunity, a stage marked by the appearance of autoantibodies against islet beta-cell proteins. Non-HLA genetic factors contribute to the risk for a first appearing islet autoantibody. Environmental etiological factors include candidate virus, but how a virus infection may yield islet autoimmunity remains to be clarified. The pathogenesis of autoimmune diabetes is characterized by a complex and prolonged autoimmune prodrome (prediabetic) phase which may last for months to years. The asymptomatic phases, Stage I (two or more autoantibodies and normoglycemia) and Stage II (two or more autoantibodies and dysglycemia), are marked by autoantibodies against either insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A), zinc transporter 8 alone, or in combination. In the third and symptomatic stage (Stage III) of disease, mononuclear cell infiltration has been detected in many but not in all patients, a beta-cell loss is significant and dysglycemia and classic symptoms of hyperglycemia develop. Lifelong insulin replacement therapy is still the only treatment. The identification of environmental determinants that trigger either IAA first or GADA first remains a major challenge to the understanding of the etiology and pathogenesis of autoimmune diabetes.

(Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Chapter in Book/Report/Conference proceeding
publication status
published
subject
keywords
Autoimmune diabetes, Environmental factors, Genetic susceptibility, HLA, Insulitis, Islet autoantibodies, Islet autoimmunity, Type 1 diabetes
host publication
The Autoimmune Diseases
editor
Rose, Noel R. and Mackay, Ian R.
edition
6
pages
769 - 787
publisher
Academic Press
external identifiers
  • scopus:85081297887
ISBN
9780128121023
9780128122426
DOI
10.1016/B978-0-12-812102-3.00041-5
language
English
LU publication?
yes
id
22cfccdc-0eb0-4428-9b8d-2fc4cbcbebfe
date added to LUP
2020-03-23 23:16:17
date last changed
2024-05-15 08:19:56
@inbook{22cfccdc-0eb0-4428-9b8d-2fc4cbcbebfe,
  abstract     = {{<p>Autoimmune (type 1) diabetes mellitus is a chronic disease without a cure. It affects primarily young people but may be diagnosed at any age. Strong genetic susceptibility characterizes the most common form of autoimmune diabetes in children younger than 18 years of age. Autoimmune diabetes is generally assumed to be hereditary, although the majority of patients do not have a family history of autoimmune diabetes. The etiology is not fully understood. However, the genetic susceptibility is strongly associated with genetic factors within the human leukocyte antigen (HLA) complex on chromosome 6. The role of HLA is associated with the development of islet autoimmunity, a stage marked by the appearance of autoantibodies against islet beta-cell proteins. Non-HLA genetic factors contribute to the risk for a first appearing islet autoantibody. Environmental etiological factors include candidate virus, but how a virus infection may yield islet autoimmunity remains to be clarified. The pathogenesis of autoimmune diabetes is characterized by a complex and prolonged autoimmune prodrome (prediabetic) phase which may last for months to years. The asymptomatic phases, Stage I (two or more autoantibodies and normoglycemia) and Stage II (two or more autoantibodies and dysglycemia), are marked by autoantibodies against either insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A), zinc transporter 8 alone, or in combination. In the third and symptomatic stage (Stage III) of disease, mononuclear cell infiltration has been detected in many but not in all patients, a beta-cell loss is significant and dysglycemia and classic symptoms of hyperglycemia develop. Lifelong insulin replacement therapy is still the only treatment. The identification of environmental determinants that trigger either IAA first or GADA first remains a major challenge to the understanding of the etiology and pathogenesis of autoimmune diabetes.</p>}},
  author       = {{Lindbladh, Ida and Svärd, Agnes Andersson and Lernmark, Åke}},
  booktitle    = {{The Autoimmune Diseases}},
  editor       = {{Rose, Noel R. and Mackay, Ian R.}},
  isbn         = {{9780128121023}},
  keywords     = {{Autoimmune diabetes; Environmental factors; Genetic susceptibility; HLA; Insulitis; Islet autoantibodies; Islet autoimmunity; Type 1 diabetes}},
  language     = {{eng}},
  month        = {{10}},
  pages        = {{769--787}},
  publisher    = {{Academic Press}},
  title        = {{Autoimmune (type 1) diabetes}},
  url          = {{http://dx.doi.org/10.1016/B978-0-12-812102-3.00041-5}},
  doi          = {{10.1016/B978-0-12-812102-3.00041-5}},
  year         = {{2019}},
}